These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35413644)

  • 1. Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial.
    Liu J; Gao LD; Fu B; Yang HT; Zhang L; Che SQ; Xu Y; Du X; Liu ZC; Xue Y; Lv CX; Huang YH; Wang BH; Gao SX; Xing YF; Yuan XH
    Phytomedicine; 2022 Jun; 100():154079. PubMed ID: 35413644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
    Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
    Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
    Wang M; Wang Z; Zhou J; Sun W; Wang Y; Han M; Yang H; Liu WJ; Wang Y
    Trials; 2018 Jul; 19(1):389. PubMed ID: 30016983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial.
    Zhao XM; Zhang Y; He XH; Chen HD; Wang ZF; Guo J; Wang XM; Gao ZZ; Wang JP; Liu W; Zhao LH; Tong XL
    Trials; 2018 Mar; 19(1):200. PubMed ID: 29587863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
    BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical metabolomics of Zicuiyin in treatment of diabetic kidney disease].
    Liu J; Zhang ZD; Lyu CX; DU X; Huang YH
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):550-558. PubMed ID: 38403329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
    Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
    PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huobahuagen tablet improves renal function in diabetic kidney disease: a real-world retrospective cohort study.
    Tan Y; Li R; Zhou P; Li N; Xu W; Zhou X; Yan Q; Yu J
    Front Endocrinol (Lausanne); 2023; 14():1166880. PubMed ID: 37404303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
    Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
    Trials; 2016 May; 17(1):259. PubMed ID: 27216240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
    Liu M; Di YM; Zhang L; Yang L; Zhang L; Chen J; Wang R; Xie X; Lan F; Xie L; Huang J; Zhang AL; Xue CC; Liu X
    Front Endocrinol (Lausanne); 2024; 15():1334609. PubMed ID: 38390199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
    Jin D; Huang WJ; Meng X; Yang F; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
    Trials; 2019 Dec; 20(1):756. PubMed ID: 31864393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease.
    Liao T; Zhao K; Huang Q; Tang S; Chen K; Xie C; Zhang C; Gan W
    Medicine (Baltimore); 2020 Jul; 99(31):e21137. PubMed ID: 32756091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan.
    Wei Y; Huang YS; Yang Z; Wang X; Li Y; Zhang Y; Zhao LH; Tong X
    Trials; 2022 Jan; 23(1):61. PubMed ID: 35057843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
    Zhang L; Li P; Xing CY; Zhao JY; He YN; Wang JQ; Wu XF; Liu ZS; Zhang AP; Lin HL; Ding XQ; Yin AP; Yuan FH; Fu P; Hao L; Miao LN; Xie RJ; Wang R; Zhou CH; Guan GJ; Hu Z; Lin S; Chang M; Zhang M; He LQ; Mei CL; Wang L; Chen X
    Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by qizhi jiangtang capsule: a multicenter randomized control clinical study].
    Guo ZA; Yu CJ; Liu G; Meng FC; Li Y; Peng SL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1047-52. PubMed ID: 25335326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective, Multicentered, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Keluoxin Capsules in the Treatment of Microalbuminuria in Patients with Type 2 Early Diabetic Kidney Disease.
    Zhao J; Wang S; Li X; Zhang G; Xu Y; Zheng X; Guo J; Zhang Z
    J Integr Complement Med; 2024 Feb; 30(2):185-195. PubMed ID: 37733303
    [No Abstract]   [Full Text] [Related]  

  • 18. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
    Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
    Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.
    Wu XQ; Zhao L; Zhao YL; He XY; Zou L; Zhao YY; Li X
    Pharm Biol; 2024 Dec; 62(1):423-435. PubMed ID: 38757785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.